Close
  Indian J Med Microbiol
 

Figure 1: MGMT promoter methylation status (measured through methylation bead chip analysis) in IDHmut gliomas in the CGGA. Data were summarized and analyzed from the CGGA database.[6] Summary of MGMT promoter methylation status in 926 WHO Grade 2–4 gliomas (A) and 635 primary and 257 recurrent WHO Grade 2–4 gliomas (B). CGGA: Chinese Glioma Genome Atlas, IDHmut: Isocitrate dehydrogenase mutation, IDHwt: Isocitrate dehydrogenase wild type, MGMT: O6-methylguanine-DNA methyltransferase, WHO: World Health Organization

Figure 1: MGMT promoter methylation status (measured through methylation bead chip analysis) in IDH<sup>mut</sup> gliomas in the CGGA. Data were summarized and analyzed from the CGGA database.<sup>[6]</sup> Summary of MGMT promoter methylation status in 926 WHO Grade 2–4 gliomas (A) and 635 primary and 257 recurrent WHO Grade 2–4 gliomas (B). CGGA: Chinese Glioma Genome Atlas, IDH<sup>mut</sup>: Isocitrate dehydrogenase mutation,  IDH<sup>wt</sup>: Isocitrate dehydrogenase wild type, MGMT: O6-methylguanine-DNA methyltransferase, WHO: World Health Organization